CCCC
Price:
$3.81
Market Cap:
$268.94M
C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting IKZF1 and IKZF3 for multiple myeloma and non-Hodgkin lymphomas, including peripheral T-cell lymphoma and mantle cell lymphoma. The company is also developing CFT8634, an orally bioavailable BiDAC degrader of BRD9, a protein target for synovial sarcoma and SMARCB1-deleted solid tumors; CFT1946, an orally bioavailable BiDAC degrader targeting V600X muta...[Read more]
Industry
Biotechnology
IPO Date
2020-10-02
Stock Exchange
NASDAQ
Ticker
CCCC
According to C4 Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -42.45%. This represents a change of 300.11% compared to the average of -10.61% of the last 4 quarters.
The mean historical ROE of C4 Therapeutics, Inc. over the last ten years is -15.52%. The current -42.45% ROE has changed 173.51% with respect to the historical average. Over the past ten years (40 quarters), CCCC's ROE was at its highest in in the March 2020 quarter at 1.23%. The ROE was at its lowest in in the March 2019 quarter at -29.09%.
Average
-15.52%
Median
-22.85%
Minimum
-53.83%
Maximum
30.46%
Discovering the peaks and valleys of C4 Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 98.05%
Maximum Annual ROE = 30.46%
Minimum Annual Increase = -177.57%
Minimum Annual ROE = -53.83%
Year | ROE | Change |
---|---|---|
2023 | -53.83% | 23.09% |
2022 | -43.74% | 98.05% |
2021 | -22.08% | -6.52% |
2020 | -23.62% | -177.57% |
2019 | 30.46% | 54.59% |
The current ROE of C4 Therapeutics, Inc. (CCCC) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-39.88%
5-year avg
-22.56%
10-year avg
-15.52%
C4 Therapeutics, Inc.’s ROE is greater than Shattuck Labs, Inc. (-61.92%), less than Eliem Therapeutics, Inc. (0%), greater than Prelude Therapeutics Incorporated (-66.88%), greater than Monte Rosa Therapeutics, Inc. (-62.68%), less than Foghorn Therapeutics Inc. (167.93%), greater than Cyteir Therapeutics, Inc. (-9.44%), greater than Rezolute, Inc. (-69.83%), greater than Century Therapeutics, Inc. (-66.58%), greater than Edgewise Therapeutics, Inc. (-26.83%), greater than Mineralys Therapeutics, Inc. (-55.92%), greater than Cullinan Oncology, Inc. (-26.54%), greater than Arvinas, Inc. (-50.26%), greater than Nurix Therapeutics, Inc. (-63.39%), greater than Kymera Therapeutics, Inc. (-24.96%), greater than Revolution Medicines, Inc. (-33.67%),
Company | ROE | Market cap |
---|---|---|
-61.92% | $52.99M | |
0% | $342.68M | |
-66.88% | $62.51M | |
-62.68% | $433.13M | |
167.93% | $276.30M | |
-9.44% | $108.71M | |
-69.83% | $255.24M | |
-66.58% | $85.88M | |
-26.83% | $2.80B | |
-55.92% | $621.11M | |
-26.54% | $710.38M | |
-50.26% | $1.27B | |
-63.39% | $1.37B | |
-24.96% | $2.64B | |
-33.67% | $8.06B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like C4 Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like C4 Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is C4 Therapeutics, Inc.'s ROE?
How is the ROE calculated for C4 Therapeutics, Inc. (CCCC)?
What is the highest ROE for C4 Therapeutics, Inc. (CCCC)?
What is the 3-year average ROE for C4 Therapeutics, Inc. (CCCC)?
What is the 5-year average ROE for C4 Therapeutics, Inc. (CCCC)?
How does the current ROE for C4 Therapeutics, Inc. (CCCC) compare to its historical average?